Search Results - "Chan, Kin Long"

Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform by Xing, Fuqiang, Liu, Yu-Cheng, Huang, Shigao, Lyu, Xueying, Su, Sek Man, Chan, Un In, Wu, Pei-Chun, Yan, Yinghan, Ai, Nana, Li, Jianjie, Zhao, Ming, Rajendran, Barani Kumar, Liu, Jianlin, Shao, Fangyuan, Sun, Heng, Choi, Tak Kan, Zhu, Wenli, Luo, Guanghui, Liu, Shuiming, Xu, De Li, Chan, Kin Long, Zhao, Qi, Miao, Kai, Luo, Kathy Qian, Ge, Wei, Xu, Xiaoling, Wang, Guanyu, Liu, Tzu-Ming, Deng, Chu-Xia

“…The feasibility of personalized medicine for cancer treatment is largely hampered by costly, labor-intensive and time-consuming models for drug discovery…”
Get full text

Efficient Organic Light-Emitting Diode through Triplet Exciton Reharvesting by Employing Blended Electron Donor and Acceptor as the Emissive Layer by Zhang, Lu, Cai, Chao, Li, King Fai, Tam, Hoi Lam, Chan, Kin Long, Cheah, Kok Wai

“…A blended bimolecular exciplex formation was demonstrated between two individual donor and acceptor molecules, which are tris­(4-carbazoyl-9-ylphenyl)­amine…”
Get full text

BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21CIP1/WAF1 by Ren, Guowen, Chen, Jinghong, Pu, Yue, Yang, Eun Ju, Tao, Shishi, Mou, Pui Kei, Chen, Li-Jie, Zhu, Wenli, Chan, Kin Long, Luo, Guanghui, Deng, Chuxia, Shim, Joong Sup

“…Loss of PTEN tumor suppressor is an important event during colorectal cancer (CRC) development and is a target for therapeutic exploitation. This study reports…”
Get full text

BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21 CIP1/WAF1 by Ren, Guowen, Chen, Jinghong, Pu, Yue, Yang, Eun Ju, Tao, Shishi, Mou, Pui Kei, Chen, Li-Jie, Zhu, Wenli, Chan, Kin Long, Luo, Guanghui, Deng, Chuxia, Shim, Joong Sup

“…Loss of PTEN tumor suppressor is an important event during colorectal cancer (CRC) development and is a target for therapeutic exploitation. This study reports…”
Get full text

Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy by Wang, Feng Hua, Yip, Yuk Ching, Zhang, Meng, Vong, Heong Ting, Chan, Kin Iong, Wai, Kit Cheng, Wen, Jian Ming

“…Glypican 3 (GPC3) is a heparan sulphate proteoglycan that shows elevated levels in the serum of patients with hepatocellular carcinoma (HCC), but not in…”
Get more information